Literature DB >> 7362779

Human tumour xenografts established and serially transplanted in mice immunologically deprived by thymectomy, cytosine arabinoside and whole-body irradiation.

P J Selby, J M Thomas, P Monaghan, J Sloane, M J Peckham.   

Abstract

Mice immunologically deprived by thymectomy, cytosine arabinoside treatment and whole-body irradiation were used to study the growth of human tumours as xenografts. 10/16 melanoma biopsies, 4/13 ovarian carcinoma biopsies and 3/6 uterine cancer biopsies grew as serially transpllantable xenograft lines. The tumour lines were studied through serial passages by histology, histochemistry, electron microscopy, chromosome analysis, immune fluorescence, growth rate measurement and mitotic counts. They retained the characteristics of the tumours of origin, with the exception of loss of pigmentation in two melanomas, histological dedifferentiation in the uterine carcinomas, and increased mitotic frequency and growth rate in some melanomas. It was concluded that this type of animal preparation is as useful as alternative methods of immunological deprivation, or as athymic nude mice, for the growth of human tumour xenografts, at least for some experimental purposes.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7362779      PMCID: PMC2010182          DOI: 10.1038/bjc.1980.7

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  15 in total

1.  Heterotransplantation model of human malignant melanoma.

Authors:  B Mukherji; A Flowers; L Nathanson; D A Clark
Journal:  Cancer Res       Date:  1974-01       Impact factor: 12.701

2.  The growth of human tumours in immune deprived mice.

Authors:  L M Cobb; B C Mitchley
Journal:  Eur J Cancer       Date:  1974-08       Impact factor: 9.162

3.  Heterotransplantation of a human malignant tumour to "Nude" mice.

Authors:  J Rygaard; C O Povlsen
Journal:  Acta Pathol Microbiol Scand       Date:  1969

4.  Heterotransplantation of human malignant melanomas to the mouse mutant nude.

Authors:  C O Povlsen
Journal:  Acta Pathol Microbiol Scand A       Date:  1976-01

5.  Growth kinetics of human large bowel cancer growing in immune-deprived mice and some chemotherapeutic observations.

Authors:  L F Lamerton; G G Steel
Journal:  Cancer       Date:  1975-12       Impact factor: 6.860

6.  Transplantation of human tumors in nude mice.

Authors:  Y Shimosato; T Kameya; K Nagai; S Hirohashi; T Koide; H Hayashi; T Nomura
Journal:  J Natl Cancer Inst       Date:  1976-06       Impact factor: 13.506

7.  The growth of human tumours in immunosuppressed mice and their response to chemotherapy.

Authors:  M C Berenbaum; C E Sheard; J R Reittie; R V Bundick
Journal:  Br J Cancer       Date:  1974-07       Impact factor: 7.640

8.  Improved immune-suppression techniques for the exongrafting of human tumours.

Authors:  G G Steel; V D Courtenay; A Y Rostom
Journal:  Br J Cancer       Date:  1978-02       Impact factor: 7.640

9.  Maintenance of biological and biochemical characteristics of human colorectal tumours during serial passage in immune-deprived mice.

Authors:  J A Houghton; D M Taylor
Journal:  Br J Cancer       Date:  1978-02       Impact factor: 7.640

10.  Growth characteristics of human colorectal tumours during serial passage in immune-deprived mice.

Authors:  J A Houghton; D M Taylor
Journal:  Br J Cancer       Date:  1978-02       Impact factor: 7.640

View more
  19 in total

Review 1.  Epithelial ovarian cancer experimental models.

Authors:  E Lengyel; J E Burdette; H A Kenny; D Matei; J Pilrose; P Haluska; K P Nephew; D B Hales; M S Stack
Journal:  Oncogene       Date:  2013-08-12       Impact factor: 9.867

2.  Tight junction proteins claudin-3 and claudin-4 control tumor growth and metastases.

Authors:  Xiying Shang; Xinjian Lin; Edwin Alvarez; Gerald Manorek; Stephen B Howell
Journal:  Neoplasia       Date:  2012-10       Impact factor: 5.715

3.  Brain tumor growth and response to chemotherapy in the subrenal capsule assay.

Authors:  M Weizsäcker; A Nagamune; K Rathmer; W Wechsler
Journal:  J Cancer Res Clin Oncol       Date:  1983       Impact factor: 4.553

4.  Clonogenic cell survival curves for human melanoma xenografts using agar diffusion chamber and lung colony assays.

Authors:  P J Selby; J M Thomas
Journal:  Br J Cancer Suppl       Date:  1980-04

5.  The combination of melphalan with prednisolone. Anti-tumor effect and normal tissue toxicity in laboratory systems.

Authors:  P J Selby; J L Millar; T A Phelps; M Y Gordon; R Wilkinson; T J McElwain
Journal:  Cancer Chemother Pharmacol       Date:  1981       Impact factor: 3.333

6.  Regulation of the Epithelial-Mesenchymal Transition by Claudin-3 and Claudin-4.

Authors:  Xinjian Lin; Xiying Shang; Gerald Manorek; Stephen B Howell
Journal:  PLoS One       Date:  2013-06-21       Impact factor: 3.240

7.  Modulation of clonogenic human melanoma cells by follicle-stimulating hormone, melatonin, and nerve growth factor.

Authors:  F L Meyskens; S E Salmon
Journal:  Br J Cancer       Date:  1981-01       Impact factor: 7.640

Review 8.  Models for measuring metabolic chemical changes in the metastasis of high grade serous ovarian cancer: fallopian tube, ovary, and omentum.

Authors:  Hannah Lusk; Joanna E Burdette; Laura M Sanchez
Journal:  Mol Omics       Date:  2021-12-06

9.  Preclinical, phase I and pharmacokinetic studies with the dimethyl phenyltriazene CB10-277.

Authors:  B J Foster; D R Newell; J Carmichael; A L Harris; L A Gumbrell; M Jones; P M Goodard; A H Calvert
Journal:  Br J Cancer       Date:  1993-02       Impact factor: 7.640

10.  Limitations of the human tumour xenograft system in individual patient drug sensitivity testing.

Authors:  M J Bailey; A J Jones; A J Shorthouse; D Raghaven; P Selby; J Gibbs; M J Peckham
Journal:  Br J Cancer       Date:  1984-11       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.